PeerView Oncology

 

PeerView Oncology
Avatar

41 y/o Female With Newly Diagnosed EGFR+ Stage 4 NSCLC and Brain Mets: Which EGFR TKIs to Consider and How to Combine Them?

By PeerView Oncology FEATURING Sandip Patel, Manmeet Ahluwalia, Kathryn Beal
By PeerView Oncology FEATURING Sandip Patel, Manmeet Ahluwalia, Kathryn Beal
114 views
May 28, 2020
Comments 0
Login to view comments. Click here to Login

Featured Video

02:58
Lilly Medical Affairs

A Heterogenous Disease with Varied Clinical Outcomes: HR+/HER2- MBC

Feat. J. O’Shaughnessy

Featured Video

06:40
Lilly Medical Affairs

Communicating the Risk of Recurrence for Patients With HR+, HER2- Ea…

Feat. J. O’Shaughnessy
Lung
17:03

Challenging Case of a 63 y/o Never-Smoking Female With TTF-1+ Lung A…

PeerView Oncology

E. Garon, J. Heymach

248 views
15:20

Locally Advanced and Early NSCLC IO Update: Will IO Change the Multi…

PeerView Oncology

B. Stiles

123 views
15:18

Managing EGFR+ NSCLC With CNS Metastases: Is There a Difference in C…

PeerView Oncology

S. Patel

388 views
02:22

45 y/o With EGFR+ NSCLC and Brain Mets: Should We Consider Mono or C…

PeerView Oncology

S. Patel, M. Ahluwalia, K. Beal

18 views
05:24

64 y/o Female With Newly Diagnosed Stage 4 NSCLC, EGFR exon 19 Mutat…

PeerView Oncology

S. Patel, M. Ahluwalia, K. Beal

22 views
17:21

Management of EGFR-Mutant Lung Cancer With Central Nervous System Me…

PeerView Oncology

S. Patel, M. Ahluwalia, K. Beal

15 views
04:37

41 y/o Female With Newly Diagnosed EGFR+ Stage 4 NSCLC and Brain Met…

PeerView Oncology

S. Patel, M. Ahluwalia, K. Beal

114 views